Prancer RTSM® Rapid clinical study start-up with Natural Language Processing (NLP)

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Europe HQ: AMSTERDAM
4G Clinical BV
Herengracht 124-128,
1015 BT, Amsterdam
The Netherlands
E: [email protected]
W: www.4gclinical.eu

US HQ: BOSTON
4G Clinical
370 Washington Street
Wellesley, MA, 02481
USA
T: +1 781-694-1400
E: [email protected]
W: www.4gclinical.com

4G Clinical is a global leader in randomisation and trial supply management (RTSM) for the life sciences industry. Our solutions, Prancer RTSM® and 4C Supply®, both leverage natural language processing (NLP) to accelerate study start-up and bring speed and flexibility to clinical trials, no matter where the science leads.

4G Clinical is headquartered in the U.S., within the Boston Biotech corridor in Wellesley, Massachusetts, alongside a West Coast office in Portland, Oregon. The company also maintains eight additional locations worldwide, with offices in Tokyo, Amsterdam, Dublin, Brussels, Tel Aviv, Basel, Nottingham, and Rheinbach.

Prancer RTSM® Rapid clinical study start-up with Natural Language Processing (NLP)

Please log in for more information